Alkermes plc
ALKS
Rank in Stocks
#2726
Alkermes plc, a biopharmaceutical company, engages in the research,... Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Share Price
$41.39
Last synced: 2026-10-16
Market Cap
$6.94B
Change (1 day)
3.22%
Change (1 year)
36.78%
Country
IE
Trade Alkermes plc (ALKS)
Category
Healthcare
Operating Margin for Alkermes plc (ALKS)
Operating Margin as of October 2026 TTM: 7.03%
According to Alkermes plc latest financial reports and stock price the company's current Operating Margin (TTM) is 7.03%. At the end of 2023 the company had an Operating Margin of 24.90%.
Operating Margin history for Alkermes plc from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 7.03% | -73.96% |
| 2024 | 27.00% | 8.43% |
| 2023 | 24.90% | -4,627.27% |
| 2022 | -0.55% | -106.60% |
| 2021 | 8.33% | -176.99% |
| 2020 | -10.82% | -27.82% |
| 2019 | -14.99% | 65.45% |
| 2018 | -9.06% | -44.65% |
| 2017 | -16.37% | -41.49% |
| 2016 | -27.98% | -21.62% |
| 2015 | -35.70% | 153.55% |
| 2014 | -14.08% | -199.09% |
| 2013 | 14.21% | 0.00% |
| 2012 | 14.21% | -162.77% |
| 2011 | -22.64% | -7.40% |
| 2010 | -24.45% | 1.28% |
| 2009 | -24.14% | -158.46% |
| 2008 | 41.29% | -3,659.48% |
| 2007 | -1.16% | -125.22% |
| 2006 | 4.60% | -43.90% |
| 2005 | 8.20% | -108.51% |
| 2004 | -96.39% | -61.15% |
| 2003 | -248.12% | 42.63% |
| 2002 | -173.96% | 50.88% |
| 2001 | -115.30% | 116.00% |
| 2000 | -53.38% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -94.51% |
US
|
|
| -149.01% | -121.20% |
US
|
|
| 25.57% | -96.36% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -95.90% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.